Search Results

1 - 4 of 4 items :

  • pharmacokinetics x
  • Dermatological and Veneral Diseases x
Clear All
The Use of Methotrexate in Dermatology / Upotreba metotreksata u dermatologiji

with traditional systemic agents. J Am Acad Dermatol 2009;61(3):451-85. 18. Chladek J, Simkova M, Vaneckova J, Hroch M, ChladkovaJ, Martinkova J, et al. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis. Eur J Clin Pharmacol 2008;64(4):347-55. 19. Asawanonda P, Nateetongrungsak Y. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of

Open access
Topical Treatment of Infantile Hemangiomas – Where Are We Now? / Topikalni tretman infantilnih hemangioma – gde smo danas?

]. 7. Volotinen M, Hakkola J, Pelkonen O, Vapaatalo H, Maenpaa J. Metabolism of ophthalmic timolol: new aspects of an olddrug. Basic Clin Pharmacol Toxicol 2011;108:297-303. 8. Zimmerman TJ, Kooner KS, Morgan KS. Safety and efficacy of timolol in pediatric glaucoma. Surv Ophthalmol 1983;28:262-4. 9. Kubota K, Yamada T, Kikuchi K, Koyama E, Ishizaki T. Pharmacokinetics and beta-blocking effects of transdermal timolol. Eur J Clin Pharmacol 1993;44:493-5. 10. Guo S, Ni N. Topical treatment for capillary hemangioma of the

Open access
Majocchi’s Granuloma in a Healthy Adult Man – a Case Report

in the treatment of Majocchi’s granuloma: a clinical and pharmacokinetic evaluation and implications for possible effectiveness in tinea capitis. Clin Exp Dermatol 1998;23:103-8. 21. Elgart ML, Warren NG. The superficial and subcutaneous mycoses. In: Moschella SL, Hurley HJ, editors. Dermatology. 3 rd ed. Philadelphia: WB. Saunders Company; 1992. p. 869-912. 22. Gupta AK, Prussick R, Sibbald RG, Knowles SR. Terbinafine in the treatment of Majocchi’s granuloma. Int J Dermatol 1995;34:189. 23. Bressan AL, Silva RS, Fonseca JC, Alves Mde F. Majocchi

Open access
Urethritis and antimicrobial resistance

(1):6-8. 27. Golparian D, Fernandes P, Ohnishi M, Jensen JS, Unemo M. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with various high-level antimicrobial resistance: potential treatment option for gonorrhea? Antimicrob Agents Chemother 2012;56(5):2739-42. 28. Still JG, Schranz J, Degenhardt TP, Scott D, Fernandes P, Gutierrez MJ, et al. Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses

Open access